Clin Mol Hepatol Volume_18 Number_3 September 2012 Relationship of visceral proteins to nutritional status in chronic and acute stress. Crit Care Med 1989;17:741-747. 17. Koda M, Murawaki Y, Mitsuda A, Oyama K, Okamoto K, Idobe Y, et al. Combination therapy with transcatheter arterial chemoemboli- zation and percutaneous ethanol injection compared with percuta- neous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study. Cancer 2001;92:1516-1524. 18. Koda M, Ueki M, Maeda Y, Mimura KI, Okamoto K, Matsunaga Y, et al. The influence on liver parenchymal function and complica- tions of radiofrequency ablation or the combination with transcath- eter arterial embolization for hepatocellular carcinoma. Hepatol Res 2004;29:18-23. 19. Giannini EG. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options. Aliment Pharmacol Ther 2006;23:1055-1065. 20. Madhotra R, Mulcahy HE, Willner I, Reuben A. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol 2002;34:81-85. 21. Thomopoulos KC, Labropoulou-Karatza C, Mimidis KP, Katsakoulis EC, Iconomou G, Nikolopoulou VN. Non-invasive predictors of the presence of large oesophagealvarices in patients with cirrhosis. Dig Liver Dis 2003;35:473-478. 22. McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion 1991;31:164-171. 23. Grabau CM, Crago SF, Hoff LK, Simon JA, Melton CA, Ott BJ, et al. Performance standards for therapeutic abdominal paracentesis. Hepatology 2004;40:484-488. 24. Pache I, Bilodeau M. Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease. Aliment Phar- macol Ther 2005;21:525-529. 25. Kodama T, Takehara T, Hikita H, Shimizu S, Li W, Miyagi T, et al. Thrombocytopenia exacerbates cholestasis-induced liver fibrosis in mice. Gastroenterology 2010;138:2487-2498, 2498.e1-7. 26. Murata K, Ito K, Yoneda K, Shiraki K, Sakurai H, Ito M. Splenectomy improves liver function in patients with liver cirrhosis. Hepatogas- troenterology 2008;55:1407-1411. 27. Lee CM, Leung TK, Wang HJ, Lee WH, Shen LK, Liu JD, et al. Evalu- ation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia. World J Gastro- enterol 2007;13:619-622. 28. Boursier J, Cesbron E, Tropet AL, Pilette C. Comparison and im- provement of MELD and Child-Pugh score accuracies for the predic- tion of 6-month mortality in cirrhotic patients. J Clin Gastroenterol 2009;43:580-585. 29. Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005;3:705-713. 308 http://dx.doi.org/10.3350/cmh.2012.18.3.302 http://www.e-cmh.org